About Taste receptor type 2 member 38
Taste receptor type 2 member 38 (TAS2R38) is a protein
from Homo sapiens identified by UniProt accession
P59533, 333 residues long.
MolForge cross-references it against 0 known binders and
76 disease associations.
Target properties
| Protein name | Taste receptor type 2 member 38 |
| UniProt accession | P59533 |
| Gene | TAS2R38 |
| Organism | Homo sapiens |
| Length | 333 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (3)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (76)
Diseases linked to this target (Open Targets).
- sensory perception of bitter taste · score 0.43
- alcohol consumption measurement · score 0.28
- diet measurement · score 0.23
- tea consumption measurement · score 0.22
- bitter alcoholic beverage consumption measurement · score 0.22
- lung adenocarcinoma · score 0.18
- breast adenocarcinoma · score 0.16
- squamous cell lung carcinoma · score 0.13
- gastric adenocarcinoma · score 0.10
- breast cancer · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P59533-F1 | alphafold | PREDICTED | 82.23 | — |
Amino-acid sequence (333 residues)
MLTLTRIRTV SYEVRSTFLF ISVLEFAVGF LTNAFVFLVN FWDVVKRQAL SNSDCVLLCL SISRLFLHGL LFLSAIQLTH FQKLSEPLNH SYQAIIMLWM IANQANLWLA ACLSLLYCSK LIRFSHTFLI CLASWVSRKI SQMLLGIILC SCICTVLCVW CFFSRPHFTV TTVLFMNNNT RLNWQIKDLN LFYSFLFCYL WSVPPFLLFL VSSGMLTVSL GRHMRTMKVY TRNSRDPSLE AHIKALKSLV SFFCFFVISS CAAFISVPLL ILWRDKIGVM VCVGIMAACP SGHAAILISG NAKLRRAVMT ILLWAQSSLK VRADHKADSR TLC
Explore Taste receptor type 2 member 38 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets